$IONS
IONIS PHARMACEUTICALS INC

2023 Q1 Form 10-K Financial Statement

#000087401523000105 Filed on February 22, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $130.5M $151.9M $587.4M
YoY Change -8.03% -65.48% -27.53%
Cost Of Revenue $1.343M $3.686M $14.12M
YoY Change -67.79% 65.59% 30.2%
Gross Profit $129.2M $148.2M $573.3M
YoY Change -6.22% -66.15% -28.31%
Gross Profit Margin 98.97% 97.57% 97.6%
Selling, General & Admin $45.52M $47.95M $150.3M
YoY Change 33.37% 27.53% -12.08%
% of Gross Profit 35.23% 32.35% 26.22%
Research & Development $197.8M $308.3M $833.1M
YoY Change 22.77% 71.67% 31.21%
% of Gross Profit 153.13% 208.01% 145.34%
Depreciation & Amortization $2.604M $3.637M $14.33M
YoY Change -39.34% -17.97% -19.68%
% of Gross Profit 2.02% 2.45% 2.5%
Operating Expenses $45.52M $356.2M $150.3M
YoY Change -76.69% 64.03% -81.35%
Operating Profit -$114.1M -$208.0M -$410.2M
YoY Change 98.5% -194.29% 6425.47%
Interest Expense $1.608M $13.44M $8.122M
YoY Change -123.81% 180.62% -24.78%
% of Operating Profit
Other Income/Expense, Net $230.0K $649.0K -$7.274M
YoY Change 22.99% -236.06% 542.01%
Pretax Income -$112.9M -$44.33M -$258.0M
YoY Change 76.28% -119.71% 785.09%
Income Tax $11.40M $8.100M $11.74M
% Of Pretax Income
Net Earnings -$124.3M -$52.43M -$269.7M
YoY Change 90.78% -123.34% 843.18%
Net Earnings / Revenue -95.25% -34.52% -45.92%
Basic Earnings Per Share -$0.87 -$0.37 -$1.90
Diluted Earnings Per Share -$0.87 -$0.37 -$1.90
COMMON SHARES
Basic Shares Outstanding 143.0M 142.1M 141.8M
Diluted Shares Outstanding 142.7M 141.8M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.783B $1.488B $1.987B
YoY Change -13.13% -29.64% -6.06%
Cash & Equivalents $309.0M $276.5M $276.5M
Short-Term Investments $1.474B $1.212B $1.710B
Other Short-Term Assets $159.7M $168.3M $168.3M
YoY Change 6.07% 17.35% 17.35%
Inventory $22.20M $22.03M $22.03M
Prepaid Expenses
Receivables $13.91M $25.54M $25.54M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.543B $2.203B $2.203B
YoY Change 12.85% -6.07% -6.07%
LONG-TERM ASSETS
Property, Plant & Equipment $85.16M $74.29M $255.8M
YoY Change -52.08% -62.11% 30.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $78.30M $75.34M $75.34M
YoY Change 32.82% 81.26% 81.26%
Total Long-Term Assets $342.6M $331.2M $331.2M
YoY Change 28.81% 24.21% 24.21%
TOTAL ASSETS
Total Short-Term Assets $2.543B $2.203B $2.203B
Total Long-Term Assets $342.6M $331.2M $331.2M
Total Assets $2.885B $2.534B $2.534B
YoY Change 14.53% -2.98% -2.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.50M $17.92M $17.92M
YoY Change -34.89% 50.55% 50.55%
Accrued Expenses $112.7M $140.1M $196.5M
YoY Change -2.66% 7.79% 51.18%
Deferred Revenue $92.34M $90.58M
YoY Change -7.3%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $8.239M $151.0K $320.0K
YoY Change 95.89% -83.69% -65.44%
Total Short-Term Liabilities $259.2M $311.6M $311.6M
YoY Change 13.47% 29.52% 29.52%
LONG-TERM LIABILITIES
Long-Term Debt $1.184B $1.176B $1.183B
YoY Change -5.09% -4.26% -3.69%
Other Long-Term Liabilities $7.487M $7.126M $466.7M
YoY Change -97.75% -98.08% 25.67%
Total Long-Term Liabilities $7.487M $1.183B $1.649B
YoY Change -99.53% -26.04% 3.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $259.2M $311.6M $311.6M
Total Long-Term Liabilities $7.487M $1.183B $1.649B
Total Liabilities $2.399B $1.961B $1.961B
YoY Change 32.56% 6.58% 6.58%
SHAREHOLDERS EQUITY
Retained Earnings -$1.554B -$1.430B
YoY Change 23.25%
Common Stock $2.090B $2.060B
YoY Change 4.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $486.6M $572.9M $572.9M
YoY Change
Total Liabilities & Shareholders Equity $2.885B $2.534B $2.534B
YoY Change 14.53% -2.98% -2.98%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$124.3M -$52.43M -$269.7M
YoY Change 90.78% -123.34% 843.18%
Depreciation, Depletion And Amortization $2.604M $3.637M $14.33M
YoY Change -39.34% -17.97% -19.68%
Cash From Operating Activities -$134.0M -$200.2M -$274.4M
YoY Change 323.36% -198.29% -990.84%
INVESTING ACTIVITIES
Capital Expenditures $10.47M $4.139M $15.72M
YoY Change -487.13% -265.43% -231.5%
Acquisitions
YoY Change
Other Investing Activities -$315.2M $216.3M -$246.9M
YoY Change 10.65% 121.58% -219.36%
Cash From Investing Activities -$325.6M $212.1M -$262.6M
YoY Change 13.25% 123.06% -234.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 492.1M -51.02M -55.30M
YoY Change -6817.91% -18.36% -122.48%
NET CHANGE
Cash From Operating Activities -134.0M -200.2M -274.4M
Cash From Investing Activities -325.6M 212.1M -262.6M
Cash From Financing Activities 492.1M -51.02M -55.30M
Net Change In Cash 32.56M -39.07M -592.7M
YoY Change -109.97% -116.53% -225.67%
FREE CASH FLOW
Cash From Operating Activities -$134.0M -$200.2M -$274.4M
Capital Expenditures $10.47M $4.139M $15.72M
Free Cash Flow -$144.5M -$204.3M -$290.1M
YoY Change 399.1% -199.1% -778.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-35480000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-269722000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-28597000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1577459000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-444263000
CY2020 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
3729000
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0
CY2020 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-35480000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-294534000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40194000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-440044000
CY2020 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
13410000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
743282000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-28597000
CY2021 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-11486000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-111000
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
11564000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
120678000
CY2021 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
16725000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
771737000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-269722000
CY2022 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-24395000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-417000
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
6373000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
100264000
CY2022 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10953000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
572887000
CY2020 us-gaap Profit Loss
ProfitLoss
-479743000
CY2022 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
0
CY2021 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
0
CY2020 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
341729000
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
46695000
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-8381000
CY2020 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
32424000
CY2022 ions Early Repayment Of Convertible Debt
EarlyRepaymentOfConvertibleDebt
0
CY2021 ions Early Repayment Of Convertible Debt
EarlyRepaymentOfConvertibleDebt
256963000
CY2020 ions Early Repayment Of Convertible Debt
EarlyRepaymentOfConvertibleDebt
0
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
90548000
CY2022 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0
CY2022 us-gaap Profit Loss
ProfitLoss
-269722000
CY2022 us-gaap Profit Loss
ProfitLoss
-269722000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.9
CY2022Q4 ions Accrued Clinical Expenses
AccruedClinicalExpenses
116460000
CY2021Q4 ions Accrued Clinical Expenses
AccruedClinicalExpenses
65730000
CY2022Q4 ions Accrued In Licensing Fees Current
AccruedInLicensingFeesCurrent
7945000
CY2021Q4 ions Accrued In Licensing Fees Current
AccruedInLicensingFeesCurrent
8044000
CY2022Q4 ions Accrued Commercial Expenses Current
AccruedCommercialExpensesCurrent
3498000
CY2021Q4 ions Accrued Commercial Expenses Current
AccruedCommercialExpensesCurrent
2471000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12198000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12315000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
140101000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
88560000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
18646000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2109000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
5770000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
164000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
390000
CY2022Q4 us-gaap Inventory Net
InventoryNet
22033000
CY2021Q4 us-gaap Inventory Net
InventoryNet
24806000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
87716000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
102653000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
74294000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
178069000
CY2022 ions Other Comprehensive Income Loss Adjustments From Purchase Of Noncontrolling Interest Of Subsidiary
OtherComprehensiveIncomeLossAdjustmentsFromPurchaseOfNoncontrollingInterestOfSubsidiary
0
CY2021 ions Other Comprehensive Income Loss Adjustments From Purchase Of Noncontrolling Interest Of Subsidiary
OtherComprehensiveIncomeLossAdjustmentsFromPurchaseOfNoncontrollingInterestOfSubsidiary
0
CY2022 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0
CY2022Q4 ions Deferred Tax Assets Interest Expense Limitation
DeferredTaxAssetsInterestExpenseLimitation
0
CY2021Q4 ions Deferred Tax Assets Interest Expense Limitation
DeferredTaxAssetsInterestExpenseLimitation
6996000
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000874015
CY2022 dei Auditor Firm
AuditorFirmId
42
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-19125
CY2022 dei Entity Registrant Name
EntityRegistrantName
Ionis Pharmaceuticals, Inc
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0336973
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
2855 Gazelle Court
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Carlsbad
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92010
CY2022 dei City Area Code
CityAreaCode
760
CY2022 dei Local Phone Number
LocalPhoneNumber
931-9200
CY2022 dei Security12b Title
Security12bTitle
Common Stock, $.001 Par Value
CY2022 dei Trading Symbol
TradingSymbol
IONS
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
false
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
3804704734
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
142953993
CY2022 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2022 dei Auditor Location
AuditorLocation
San Diego, California
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7126000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6946000
CY2021 us-gaap Profit Loss
ProfitLoss
-28597000
CY2020 us-gaap Profit Loss
ProfitLoss
-479743000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-444263000
CY2022 us-gaap Profit Loss
ProfitLoss
-269722000
CY2021 us-gaap Profit Loss
ProfitLoss
-28597000
CY2020 us-gaap Profit Loss
ProfitLoss
-479743000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-24395000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-11486000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3729000
CY2022 ions Other Comprehensive Income Loss Adjustments From Purchase Of Noncontrolling Interest Of Subsidiary
OtherComprehensiveIncomeLossAdjustmentsFromPurchaseOfNoncontrollingInterestOfSubsidiary
0
CY2021 ions Other Comprehensive Income Loss Adjustments From Purchase Of Noncontrolling Interest Of Subsidiary
OtherComprehensiveIncomeLossAdjustmentsFromPurchaseOfNoncontrollingInterestOfSubsidiary
0
CY2020 ions Other Comprehensive Income Loss Adjustments From Purchase Of Noncontrolling Interest Of Subsidiary
OtherComprehensiveIncomeLossAdjustmentsFromPurchaseOfNoncontrollingInterestOfSubsidiary
-127000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-294534000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-40194000
CY2020 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-475524000
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
617000
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
52034000
CY2020 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
544686000
CY2020 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
90549000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
230117000
CY2020 ions Adjustments To Additional Paid In Capital Deferred Tax Liability Adjustment
AdjustmentsToAdditionalPaidInCapitalDeferredTaxLiabilityAdjustment
7714000
CY2020 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
-35480000
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
89752000
CY2021 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-136620000
CY2021 us-gaap Profit Loss
ProfitLoss
-28597000
CY2022 ions Increase Decrease In Income Taxes Receivable Payable
IncreaseDecreaseInIncomeTaxesReceivablePayable
0
CY2021 ions Increase Decrease In Income Taxes Receivable Payable
IncreaseDecreaseInIncomeTaxesReceivablePayable
-1008000
CY2020 ions Increase Decrease In Income Taxes Receivable Payable
IncreaseDecreaseInIncomeTaxesReceivablePayable
89000
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
632500000
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
CY2022 ions Royalty Monetization Issuance Costs
RoyaltyMonetizationIssuanceCosts
29000
CY2021 ions Royalty Monetization Issuance Costs
RoyaltyMonetizationIssuanceCosts
0
CY2020 ions Royalty Monetization Issuance Costs
RoyaltyMonetizationIssuanceCosts
0
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
15609000
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2021 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0
CY2020 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
544686000
CY2022 ions Number Of Significant Customers
NumberOfSignificantCustomers
1
CY2021 ions Number Of Significant Customers
NumberOfSignificantCustomers
2
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.2
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-444464000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
139612000
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.18
CY2020 ions Other Comprehensive Income Loss Adjustments From Purchase Of Noncontrolling Interest Of Subsidiary
OtherComprehensiveIncomeLossAdjustmentsFromPurchaseOfNoncontrollingInterestOfSubsidiary
-127000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-24812000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11597000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4219000
CY2021 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0
CY2020 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
19760000
CY2022Q4 ions Net Proceeds From Sale Of Buildings And Land
NetProceedsFromSaleOfBuildingsAndLand
202600000
CY2022 us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
150100000
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2019Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
125000000
CY2019 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
535000
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
34400000
CY2020Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1500000
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
90500000
CY2021Q4 ions Incremental Common Shares Attributable To Employee Stock Purchase Plan
IncrementalCommonSharesAttributableToEmployeeStockPurchasePlan
34000
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
226210000
CY2022 ions Effective Income Tax Rate Reconciliation Acquisition Of Noncontrolling Interest Amount
EffectiveIncomeTaxRateReconciliationAcquisitionOfNoncontrollingInterestAmount
0
CY2022 ions Effective Income Tax Rate Reconciliation Acquisition Of Noncontrolling Interest Percent
EffectiveIncomeTaxRateReconciliationAcquisitionOfNoncontrollingInterestPercent
0
CY2021 ions Effective Income Tax Rate Reconciliation Acquisition Of Noncontrolling Interest Amount
EffectiveIncomeTaxRateReconciliationAcquisitionOfNoncontrollingInterestAmount
0
CY2021 ions Effective Income Tax Rate Reconciliation Acquisition Of Noncontrolling Interest Percent
EffectiveIncomeTaxRateReconciliationAcquisitionOfNoncontrollingInterestPercent
0
CY2020 ions Effective Income Tax Rate Reconciliation Acquisition Of Noncontrolling Interest Amount
EffectiveIncomeTaxRateReconciliationAcquisitionOfNoncontrollingInterestAmount
-22032000
CY2020 ions Effective Income Tax Rate Reconciliation Acquisition Of Noncontrolling Interest Percent
EffectiveIncomeTaxRateReconciliationAcquisitionOfNoncontrollingInterestPercent
0.164
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-52430000
CY2021Q4 us-gaap Profit Loss
ProfitLoss
224613000
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
224612000
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141205000
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.59
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
160340000
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.41

Files In Submission

Name View Source Status
ions-20221231_lab.xml Edgar Link unprocessable
ions-20221231_cal.xml Edgar Link unprocessable
0000874015-23-000105-index-headers.html Edgar Link pending
0000874015-23-000105-index.html Edgar Link pending
0000874015-23-000105.txt Edgar Link pending
0000874015-23-000105-xbrl.zip Edgar Link pending
exhibit10-10.htm Edgar Link pending
exhibit10-13.htm Edgar Link pending
exhibit10-14.htm Edgar Link pending
exhibit10-16.htm Edgar Link pending
exhibit10-23.htm Edgar Link pending
exhibit10-24.htm Edgar Link pending
exhibit10-25.htm Edgar Link pending
exhibit10-26.htm Edgar Link pending
exhibit10-27.htm Edgar Link pending
exhibit10-28.htm Edgar Link pending
exhibit10-29.htm Edgar Link pending
exhibit10-80.htm Edgar Link pending
exhibit10-81.htm Edgar Link pending
exhibit14.htm Edgar Link pending
exhibit21-1.htm Edgar Link pending
exhibit23-1.htm Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10k.htm Edgar Link pending
image0.jpg Edgar Link pending
image07.jpg Edgar Link pending
image1.jpg Edgar Link pending
image11.jpg Edgar Link pending
image2.jpg Edgar Link pending
image3.jpg Edgar Link pending
image4.jpg Edgar Link pending
image5.jpg Edgar Link pending
image6.jpg Edgar Link pending
image7.jpg Edgar Link pending
image8.jpg Edgar Link pending
ions-20221231.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10k_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
ions-20221231_def.xml Edgar Link unprocessable
ions-20221231_pre.xml Edgar Link unprocessable
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending